Your browser doesn't support javascript.
loading
Assessment and non-clinical impact of medical devices.
Dervaux, Benoît; Szwarcensztein, Karine; Josseran, Anne; Barna, Alexandre; Carbonneil, Cédric; Chevrie, Karine; Debroucker, Frédérique; Grumblat, Anne; Grumel, Olivier; Massol, Jacques; Maugendre, Philippe; Méchin, Hubert; Orlikowski, David; Roussel, Christophe; Rumeau-Pichon, Catherine; Sales, Jean-Patrick; Vicaut, Eric.
  • Dervaux B; Faculté de Médecine, CHRU, Lille, France.
  • Szwarcensztein K; Johnson & Johnson Produits de Santé, Issy-les-Moulineaux, France.
  • Josseran A; SNITEM, Courbevoie, France.
  • Barna A; CEDIT, Paris, France.
  • Carbonneil C; Direction Générale de l'Organisation des Soins, Ministère des Affaires Sociales, de la Santé et des Droits des Femmes, Paris, France.
  • Chevrie K; EOS Imaging, Paris, France.
  • Debroucker F; Medtronic France, Boulogne-Billancourt, France.
  • Grumblat A; CHU, Besançon, France.
  • Grumel O; Baxter France, Maurepas, France.
  • Massol J; Institut Phisquare, Paris, France.
  • Maugendre P; Sanofi France, Paris, France.
  • Méchin H; Helsia, Paris, France.
  • Orlikowski D; Hôpital Universitaire Raymond Poincaré, Garches, France.
  • Roussel C; 3M France, Paris, France.
  • Rumeau-Pichon C; Haute Autorité de Santé, Saint-Denis, France.
  • Sales JP; Haute Autorité de Santé, Saint-Denis, France.
  • Vicaut E; Hôpitaux Universitaires Saint-Louis Lariboisière, Paris, France.
Therapie ; 70(1): 57-68, 2015.
Article en En, Fr | MEDLINE | ID: mdl-25747839
ABSTRACT
Medical devices (MDs) cover a wide variety of products. They accompany changes in medical practice in step with technology innovations. Innovations in the field of MDs can improve the conditions of use of health technology and/or modify the organisation of care beyond the strict diagnostic or therapeutic benefit for the patients. However, these non purely clinical criteria seem to be only rarely documented or taken into account in the assessment of MDs during reimbursement decisions at national level or for formulary listing by hospitals even though multidimensional models for the assessment of health technologies have been developed that take into account the views of all stakeholders in the healthcare system In this article, after summarising the background concerning the assessment of health technologies in France, a definition of non-clinical criteria for the assessment of MDs is proposed and a decision tree for the assessment of MDs is described. Future lines of approach are proposed as a conclusion.
Asunto(s)

Texto completo: 1 Ejes tematicos: Inovacao_tecnologica Banco de datos: MEDLINE Asunto principal: Evaluación de la Tecnología Biomédica / Equipos y Suministros Tipo de estudio: Guideline / Health_technology_assessment / Prognostic_studies Límite: Humans País como asunto: Europa Idioma: En / Fr Año: 2015 Tipo del documento: Article

Texto completo: 1 Ejes tematicos: Inovacao_tecnologica Banco de datos: MEDLINE Asunto principal: Evaluación de la Tecnología Biomédica / Equipos y Suministros Tipo de estudio: Guideline / Health_technology_assessment / Prognostic_studies Límite: Humans País como asunto: Europa Idioma: En / Fr Año: 2015 Tipo del documento: Article